ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HEMO Hemogenyx Pharmaceuticals Plc

1.65
0.065 (4.10%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hemogenyx Pharmaceuticals Plc LSE:HEMO London Ordinary Share GB00BYX3WZ24 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.065 4.10% 1.65 1.622 1.678 1.68 1.622 1.65 1,887,786 16:35:10
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.98M -0.0035 -4.63 18.5M
Hemogenyx Pharmaceuticals Plc is listed in the Finance Services sector of the London Stock Exchange with ticker HEMO. The last closing price for Hemogenyx Pharmaceuticals was 1.59p. Over the last year, Hemogenyx Pharmaceuticals shares have traded in a share price range of 1.125p to 6.30p.

Hemogenyx Pharmaceuticals currently has 1,141,999,321 shares in issue. The market capitalisation of Hemogenyx Pharmaceuticals is £18.50 million. Hemogenyx Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.63.

Hemogenyx Pharmaceuticals Share Discussion Threads

Showing 12151 to 12170 of 13425 messages
Chat Pages: Latest  489  488  487  486  485  484  483  482  481  480  479  478  Older
DateSubjectAuthorDiscuss
09/1/2023
12:48
Using the Company's expertise in developing cell therapies for cancer, it developed an approach that can be used to bring cell therapy approaches to another unmet need, the treatment of major existing and emerging viral infections, including SARS-CoV-2
the chairman elect
09/1/2023
12:47
The Directors believe that this significant discovery of a single target protein for use against multiple dangerous viruses is further evidence of the potential power of the Company's CBR technology, and demonstrates the possibility of accelerating the development of antiviral therapeutics as well as preventing epidemics and pandemics that could be caused by a multitude of pathogens.
the chairman elect
09/1/2023
12:45
Single CBR Can Treat Multiple Viruses

Hemogenyx Pharmaceuticals plc (LSE: HEMO) announces that it has made significant progress towards the practical use of its Chimeric Bait Receptor ("CBR") platform technology, designed to program immune cells to eliminate viral infections by destroying the viruses that cause them. The Company's scientists have identified a target protein that can be incorporated into a single multipurpose CBR-based therapeutic capable of treating multiple viruses that belong to different viral families, instead of having to make a separate CBR construct for every virus. Among them are Dengue, Ebola, Marburg, Zika and Chikungunya. These viruses are among the most dangerous to humans, causing serious and often fatal diseases, and for which few effective treatment options exist.

the chairman elect
09/1/2023
12:43
This site is infested with vermin TROLLs all of whom require culling ASAP
the chairman elect
09/1/2023
12:41
Yes just as with all the TROLLs
the chairman elect
09/1/2023
12:39
You sound bitter 'truth'.Same rant on pyc.
lean5gb
09/1/2023
12:35
Yes the premium placement with the super major US player no doubt!
the chairman elect
09/1/2023
12:33
Certainly a placing coming at 16p.
bigalan3
09/1/2023
12:14
Massive LOLs @ all the desperate de-rampers
the chairman elect
09/1/2023
12:13
Placing is going to be big discount
truthcaller
09/1/2023
12:03
LOL - refer the latest TROLL to POST 8265
the chairman elect
09/1/2023
12:02
Placing soon
ridingthewaves1
09/1/2023
11:48
New intra day highs
the chairman elect
09/1/2023
11:42
But I doubt it as I have not had one and my post 8265 explains the most likely reason why not!!!!
the chairman elect
09/1/2023
11:40
If you have had one you should NOT be posting as it id against the law!
the chairman elect
09/1/2023
11:36
Yes we all know what a market sounding is so what is your point?
the chairman elect
09/1/2023
11:32
*market sounding... if you know you know
epifanio1
09/1/2023
11:28
If the market whispers of a JV with a super major US player [additionally will make a strategic investment at a premium] comes to pass then HEMO will almost certainly be trading north of 10p
the chairman elect
09/1/2023
11:22
HEMO heading higher on very decent volumes....
the chairman elect
09/1/2023
10:33
badger609 Jan '23 - 10:31 - 8259 of 8260 (Filtered)
the chairman elect
Chat Pages: Latest  489  488  487  486  485  484  483  482  481  480  479  478  Older

Your Recent History

Delayed Upgrade Clock